![Michael Conway](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Conway
Corporate Officer/Principal bij METAGENOMI, INC.
Oorsprong van het eerstegraads netwerk van Michael Conway
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 15 | |
Adamas Pharmaceuticals, Inc.
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Conway via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Florida | College/University | Graduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
CARIBOU BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
NEA Management Co. LLC
![]() NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
University of Madras | College/University | Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree | |
Columbia University Medical Center | College/University | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Texas A&M University | College/University | Graduate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
New Enterprise Associates LLC
![]() New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aleva Neurotherapeutics SA
![]() Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland. | Electronic Equipment/Instruments | Director/Board Member | |
Oerth Bio LLC
![]() Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Biotechnology | Director/Board Member | |
Joyn Bio LLC
![]() Joyn Bio LLC Real Estate DevelopmentFinance Joyn Bio LLC is a joint venture between Leaps by Bayer and Ginkgo Bioworks that engineers microbes to improve naturally occurring processes in agriculture. The company is based in Boston, MA, and has two sites for leading scientists with diverse backgrounds. The company's focus is on developing probiotics for plants to provide growers with next-generation solutions to their biggest challenges. The company's first area of focus is on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture's reliance on nitrogen fertilizer and its environmental impact. | Real Estate Development | Director/Board Member | |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Casebia Therapeutics LLP
![]() Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Plant Response, Inc.
![]() Plant Response, Inc. Agricultural Commodities/MillingProcess Industries Plant Response, Inc. is engaged in providing agricultural biological services. It offers cybelion, power coat, biohp, neptunion, biopath and PRB9 products. The company is headquartered in Durham, NC. | Agricultural Commodities/Milling | Director/Board Member | |
Pairwise Plants Services
![]() Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC. | Food: Major Diversified | Director/Board Member | |
9905553 Canada, Inc.
![]() 9905553 Canada, Inc. Internet Software/ServicesTechnology Services 9905553 Canada, Inc. operates as a digital market place that allows buyers and sellers to list, negotiate, and finalize grain deals. The company was founded by Brennan Turner and Alain Goubau and is headquartered in Ontario, Canada. | Internet Software/Services | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
![]() Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
University of Basel | College/University | Doctorate Degree | |
Anteis SA
![]() Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Medical/Nursing Services | Director/Board Member | |
swiss smile Holding AG
![]() swiss smile Holding AG Medical/Nursing ServicesHealth Services swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Cameron Health, Inc.
![]() Cameron Health, Inc. Medical SpecialtiesHealth Technology Cameron Health, Inc. develops medical devices for patients and medical professionals. It has developed a totally subcutaneous implantable defibrillator (S-ICD) system that remedies many of the issues associated with traditional implantable cardioverter defibrillators. The company was founded on August 21, 2000 and is headquartered in San Clemente, CA. | Medical Specialties | Director/Board Member | |
TargeGen, Inc.
![]() TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Kleiner Perkins Caufield & Byers LLC
![]() Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Private Equity Investor | |
UCB, Inc.
![]() UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Financial Conglomerates | Corporate Officer/Principal | |
Diality, Inc.
![]() Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Medical Specialties | Director of Finance/CFO | |
Fosun Kite Biotechnology Co., Ltd.
![]() Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Biotechnology | Chief Tech/Sci/R&D Officer | |
HAYA Therapeutics SA
![]() HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Biotechnology | Chairman | |
University of Kansas | College/University | Doctorate Degree | |
Berkeley University of California | College/University | Corporate Officer/Principal | |
Capsida Biotherapeutics, Inc.
![]() Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
True North Therapeutics, Inc.
![]() True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO |
Statistieken
Internationaal
Verenigde Staten | 37 |
Zwitserland | 7 |
Duitsland | 3 |
Canada | 3 |
India | 2 |
Sectoraal
Health Technology | 21 |
Consumer Services | 12 |
Finance | 9 |
Commercial Services | 5 |
Health Services | 4 |
Operationeel
Director/Board Member | 76 |
Corporate Officer/Principal | 36 |
Chief Tech/Sci/R&D Officer | 18 |
Undergraduate Degree | 14 |
Independent Dir/Board Member | 14 |
Sterkste connecties
Insiders | |
---|---|
Jürgen Eckhardt | 34 |
Risa Stack | 26 |
Sebastián Bernales | 19 |
Sarah Noonberg | 17 |
Willard Dere | 16 |
Santhosh Palani | 15 |
Jian Irish | 10 |
Luis Borges | 9 |
Pamela Wapnick | 9 |
Neil McFarlane | 7 |
Simon Harnest | 7 |
Brian Thomas | 5 |
Simren Delaney | 5 |
Alan Brooks | 5 |
Christopher Brown | 4 |
- Beurs
- Insiders
- Michael Conway
- Bedrijfsconnecties